Foley Hoag represented Ginkgo Bioworks on the deal. Ginkgo Bioworks (NYSE: DNA) (“Ginkgo”), the leading platform for cell programming and biosecurity, announced its acquisition of StrideBio’s adeno-associated...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Lantheus Holdings on the deal. Lantheus Holdings (Nasdaq: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions,...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Applied Genetic Technologies Corporation (“AGTC”) on the deal. Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC”), a clinical-stage biotechnology company focused on the development...
You must be a Standard 1 Year member to access this content.
